Trans Abdominis Plane (TAP) Block in Patients With Cesarean Section

Analgesia Clinical Trial

— TAP  

Official title:

Analgesic Efficacy of Trans Abdominis Plane Block in Women Undergoing Cesarean Section: a Randomized Study.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04809532
• Other study ID #: 1506/ERC/Training
• Status: Recruiting
• Phase: N/A
• Start date: February 25, 2021
• Est. completion date: April 30, 2021

Study information

• Verified date: March 2021
• Source: Armed Forces Hospital, Pakistan
• Contact: Arshad Khushdil, FCPS
• Phone: +92 3463300030
• Email: drarshad104589[@]yahoo.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Objective: To compare Trans Abdominis Plane block in providing post cesarean analgesia with control group, in terms of mean postoperative use of Opioids.

Study design: Randomized controlled trial. Place and duration Department of Anesthesiology, Combined Military Hospital, Sargodha, 25th February 2021 to 25th April 2021.

Materials and methods: A total of 60 female patients, who are planned to undergo elective c section and aged between 20-45 will be selected randomly and divided into two groups ( A and B) with 30pts each group. In Group A, at the end of surgery, TAP block will be given with 20ml of 0.25%bupvicaine via ultrasound guided sub-costal approach on both sides of midline. Time of TAP block will be recorded as time 0. Our outcomes will be: mean postoperative consumption of opioids and VAS score within 24hrs of surgery. Independent t test will be used to compare group A and B in terms of mean usage of tramadol within 24hrs of surgery. P value <0.05 will be considered statistically significant.

Description:

Analgesic efficacy of trans abdominis plane block in women undergoing Cesarean section: a randomized controlled trial.

Introduction:

Cesarean section is considered as one of the most commonly performed surgery worldwide. Based on the data from 121 countries, the trend analysis showed that between 1990 and 2014, the global average CS rate increased 12.4% (from 6.7% to 19.1%) with an average annual rate of increase of 4.4%.Its incidence in 2010 and 2013 was 41.9% and 48% respectively which was contrary to the rate of C/S recommended by the World Health Organization as fifteen percent for year 2014 .Just like all other major abdominal surgeries, c section comes with severe postoperative pain ,which if not managed properly can not only leads to prolonged immobility and its associated adverse effects but can also affect mother-baby bonding, care of baby, breast feeding and may lead to chronic pain and post-partum depression Multiple modalities are available for managing this post cesarean pain. Mostly systemic opioids are used but they are often associated with a number of undesirable side effects such as nausea, vomiting, pruritus, constipation, and respiratory depression,sedation.Other than opoids, systemic NSAIDS such as ketorolac, acetoaminophen are also used but alone they may be insufficient to treat post cesarean pain. Other analgesic options currently being used include local anesthetic techniques (local anesthetic infiltration, neuraxial blocks) acetaminophen , cyclooxygenase-2-specific inhibitors as well as analgesic adjuncts such as steroids, ketamine and α-2 agonists such as clonidine.

Neruoaxial anesthesia such as lumbar or thoracic epidurals are also used but because of constant and strict monitoring ,they are not considered economical for patients as well as for hospitals. With recent advancements in regional anesthesia, some regional blocks are now being utilized for postoperative pain relief in c sections such as TAP blocks but their use is still limited because of nonavailability of sufficient data.

Transversus abdominis plane (TAP) block provides analgesia by blocking nerves in anterior abdominal wall through introduction of a long-acting local anesthetic solution between the internal oblique and transversus abdominis muscles. Its use in c section is still limited ,but is considerd to be increased in future as is now been shown by several studies .

One of these studies is done by Uma Srivastava and collegues which showed that cumulative tramadol usage during first 24 h after surgery was significantly reduced in women given TAP block in comparison to control group C (75 ± 22 vs. 168 ± 45 mg in groups B and C, respectively, P < 0.0001.

As no local study is available and in the light of above mentioned studies, we proposed that with bilateral TAP block after c section you can provide better analgesia and improve patient's quality of life in postoperative period by reducing opoid usage and its associated side effects .

OBJECTIVE:

To compare TAP block in providing post cesarean analgesia with control group, in terms of mean reduction in postoperative use of opoids.

OPERATIONAL DEFINITIONS:

TAP block: injection of 20ml 0.25% bupvicaine given between internal oblique and transversus abdominis muscle on both sides of midline with no intervention in control group.

VAS (visual analogue score) : VAS , a linear scale that identifies the pain by the self-report of patient, and it is considered as gold standard for evaluation of pain in conscious patients 7. VAS >4 trigger for inj tramadol 1mg/kg i/v.

Analgesic consumption:- postoperative consumption of injection tramadol will be measured within 24hrs after surgery .

HYPOTHESIS:

TAP block is a safe and effective option to control postoperative analgesia after c section by reducing postoperative consumption of opioids.

MATERIALS AND METHODS:

Study design: Randomized control trial Sampling technique: Consecutive non-probability sampling Sample size: Using the study by Uma Srivastava at el, the results of which showed efficacy of TAP block in terms of cumulative tramadol usage during first 24 h after surgery in study group vs control group C as (75 ± 22 vs. 168 ± 45 mg in groups B and C ) and with the help of WHO sample size calculator, following calculations were made Level of significance: 5% Confidence interval: 95% Power of test: 80% Sample size=n= 6 patients in each group As sample size is very small, minimum 30 pts in each group will be used Group A: TAP block will be given Group B: no TAP block will be given Setting: Anesthesia department, Combined Military Hospital, Sargodha ,Pakistan. Duration: After approval from ethical committee Source: Admitted patient Patients will be allocated to two groups A or B, using lottery method. All patients will be assessed on day of surgery and written informed consent will be taken after explaining all the risks and benefits to patient.

On day of surgery, patients will be prepared for surgery and spinal anesthesia as per institutional protocols. Every patient will be given 1.5ml of 0.75% bupivacaine intrathecally to provide anesthesia for c section by consultant anesthetist. During surgery no drug other than oxytocin and anti-emetic (if required) will be given. In group A, at the end of surgery, TAP block will be given via ultrasound guided subcostal approach on both sides of midline. After strict monitoring for next 15-20mins,pt will be shifted to PACU. Time of TAP block will be recorded as time 0.

In ward , all patients will be given analgesia as per departmental protocol (injection ketorolac 30mg i/v TDS).In postoperative period intensity of pain and opioid consumption within 24hrs of surgery will be recorded. Performa till the application of TAP block will be filled by treating anesthetist, whereas remaining will be filled by trainee anesthesia.

After collecting all data, data would be entered and analyzed using SPSS Version 16.

Descriptive statistics will be used to calculate quantitative and qualitative variables. Mean and SD will be calculated for quantitative variables i.e. age weight, intensity of pain, dosage of opioids. Frequency and percentage will be calculated for qualitative variables i.e. gender. P value <0.05 will be considered statistically significant. All results would be presented as frequency tables. Effect modifiers like weight and age will be controlled by stratification and post stratification independent sample t test will be used.

Independent t test will be used to compare group A and B in terms of mean usage of tramadol within 24hrs of surgery.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: April 30, 2021
• Est. primary completion date: April 25, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 20 Years to 45 Years

Eligibility

Inclusion Criteria:

• Age: 20 and 45 years

• Elective cesarean

• Fit to undergo surgery under spinal anesthesia

Exclusion Criteria:

Patients who will have

• Any contraindication to spinal anesthesia

• ASA class III and IV

• Known Allergic to local anesthetic

• Eclampsia

• Placenta accreta/percretra

Related Conditions & MeSH terms

• Analgesia
• Cesarean Section Complications

Intervention

Procedure:
• Transverse abdominis plane (TAP) block
Ultrasound guide bilateral TAP block at end of cesarean section

Drug:
• Bupivacain
20ml 0.25% bupvicaine
• Tramadol
intravenous tramadol

Locations

Country	Name	City	State
Pakistan	Madiha Ahmed	Islamabad
Pakistan	Department of Pediatrics	Rawalpindi	Punjab

Sponsors (1)

Lead Sponsor	Collaborator
Armed Forces Hospital, Pakistan

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	postoperative consumption of opioids	questionnaire will be filled 24hours after the surgery by trainee anesthesia and he/she will document the total consumption of intravenous tramadol after surgery	24hours after surgery